Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids
Source Wu et al., 2024 · Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences · 10.1097/hc9.0000000000000585
Abstract
A protocol for generating human liver organoids (HLOs) from induced pluripotent stem cells and inducing metabolic-associated steatohepatitis (MASH) features through oleic acid and TGFβ treatment. The M-HLO model demonstrates lipid accumulation, oxidative stress, mitochondrial dysfunction, inflammation, and fibrosis, enabling MASH pathogenesis study and drug screening.
Protocol overview
36 steps across 9 phases
- 1 iPSC culture initialization
- 2 Day 1 – Definitive endoderm induction
- 3 Day 2 – Activin A treatment with reduced serum
- 4 Day 3 – Increased serum concentration
- 5 Days 4–6 – Foregut cell differentiation
- 1 Day 7 – Foregut dissociation and Matrigel embedding
- 2 Days 7–10 – 5F medium culture
- 3 Days 10–14 – Retinoic acid-driven maturation
- 1 Day 15 – Harvest and transfer to hepatocyte maturation medium
- 2 Days 16–20 – Complete maturation with medium changes
- 1 Day 20 – Plate HLOs for MASH induction
- 2 Days 20–27 – OA+TGFβ treatment (4 days OA, then 3 days OA+TGFβ)
- 3 Vehicle control treatment
- 4 Optional: Herbal extract treatment
- 1 BODIPY staining for lipid droplet visualization
- 2 TMRM staining for mitochondrial membrane potential assessment
- 3 CellROX staining for oxidative stress evaluation
- 4 TUNEL assay for apoptosis detection
- 5 Collagen I immunofluorescence staining for fibrogenesis assessment
- 1 Total RNA isolation
- 2 Reverse transcription
- 3 Quantitative real-time PCR (RT-qPCR)
- 1 Collect culture supernatant
- 2 Human albumin ELISA
- 3 Human MCP-1 (CCL2) ELISA
- 4 Human IL-6 ELISA
- 1 RNA extraction for bulk RNA-seq
- 2 Library preparation and sequencing
- 3 KEGG pathway enrichment analysis
- 1 Single cell dissociation and preparation
- 2 scRNA-seq library preparation
- 3 Data processing and quality control
- 4 Cell-type annotation and clustering
- 5 Differential expression analysis
- 6 Intercellular communication analysis
- 7 Pseudotime trajectory analysis
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Wu et al., 2024. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol